PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11081569-0	2000	The tegafur-based dihydropyrimidine dehydrogenase inhibitory fluoropyrimidines, UFT/leucovorin (ORZEL) and S-1: a review of their clinical development and therapeutic potential.	Tegafur-Uracil	96-101	dihydropyrimidine dehydrogenase	Homo sapiens	18-49	
11241325-4	2001	UFT (uracil:tegafur) plus oral leucovorin (Orzel) is the first oral DPD-inhibitory fluoropyrimidine.	Tegafur-Uracil	43-48	dihydropyrimidine dehydrogenase	Homo sapiens	68-71	
17637782-1	2008	Uracil-Ftorafur (UFT) combines the 5-fluorouracil (FU) prodrug tegafur with uracil (at a 1:4 molar ratio), which is a competitive inhibitor of dihydropyrimidine dehydrogenase (DPD), the limiting enzyme of FU catabolism.	Tegafur-Uracil	17-20	dihydropyrimidine dehydrogenase	Homo sapiens	143-174	
17637782-1	2008	Uracil-Ftorafur (UFT) combines the 5-fluorouracil (FU) prodrug tegafur with uracil (at a 1:4 molar ratio), which is a competitive inhibitor of dihydropyrimidine dehydrogenase (DPD), the limiting enzyme of FU catabolism.	Tegafur-Uracil	17-20	dihydropyrimidine dehydrogenase	Homo sapiens	176-179